NGM Biopharmaceuticals Inc (NASDAQ:NGM)

13.78
Delayed Data
As of May 27
 +0.39 / +2.91%
Today’s Change
10.49
Today|||52-Week Range
27.25
-22.19%
Year-to-Date
No recent news for NGM Biopharmaceuticals Inc.

Today’s Trading

Previous close13.39
Today’s open13.74
Day’s range13.40 - 13.84
Volume6,176
Average volume (3 months)294,333
Market cap$1.1B
Data as of 4:00pm ET, 05/27/2022

Growth & Valuation

Earnings growth (last year)-4.30%
Earnings growth (this year)-32.31%
Earnings growth (next 5 years)--
Revenue growth (last year)-10.86%
P/E ratioNM
Price/Sales17.53
Price/Book3.22

Competitors

 Today’s
change
Today’s
% change
IOVAIovance Biotherapeut...-8.11-53.60%
SAVACassava Sciences Inc+1.17+4.59%
ALLOAllogene Therapeutic...+0.50+6.67%
MYOVMyovant Sciences Ltd+0.83+8.28%
Data as of 5:11pm ET, 05/27/2022

Financials

Next reporting dateAugust 16, 2022
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$77.9M
Annual profit (last year)-$120.3M
Net profit margin-154.51%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts